BUILDING A BUSINESS

Integrating scientific considerations into R&D project valuation

Traditional valuation approaches rarely take into account scientific considerations specific to a R&D project. A question-based approach using real options offers a solution.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Decision tree of the younamamab case based on the QBCD analysis using the QOC tool.

References

  1. 1.

    Bogdan, B. & Villiger, R. Valuation in Life Sciences, A Practical Guide (Springer-Verlag, 2007)

  2. 2.

    Stewart, J. J., Allison, P. N. & Johnson, R. S. Nat. Biotechnol. 19, 813–817 (2001).

  3. 3.

    Kola, I. & Landis, J. Nat. Rev. Drug Discov. 3, 711–715 (2004).

  4. 4.

    Johal, S. S., Oliver, P. & Williams, H. C. J. Med. Mark. 8, 101–112 (2008).

  5. 5.

    Pietzsch, J. B., Shluzas, L. A., Paté-Cornell, M. E., Yock, P. G. & Linehan, J. H. J. Med. Dev. 3, 021004-1–021004-15 (2009).

  6. 6.

    ICH Expert Working Group. ICH Harmonised Tripartite Guideline: General Considerations for Clinical Trials E8, Step 4 version (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1997).

  7. 7.

    Huchzermeier, A. & Loch, C. H. Manag. Sci. 47, 85–101 (2001).

  8. 8.

    Harrison, M. H. & Lerer, L. Nat. Biotechnol. 29, 223 (2002).

  9. 9.

    Stewart, J. J. Nat. Biotechnol. 29, 223–224 (2002).

  10. 10.

    Villiger, R. & Bogdan, B. Drug Discov. Today 9, 552–553 (2004).

  11. 11.

    Nichols, N. Harv. Bus. Rev. 72, 89–99 (1994).

  12. 12.

    Hartmann, M. & Ali Hassan, A. Res. Policy 35, 343–354 (2006).

  13. 13.

    Evers, R. et al. Clin. Pharmacol. Ther. 96, 291–295 (2014).

  14. 14.

    Dolgos, H. et al. Drug Discov. Today 21, 517–526 (2016).

  15. 15.

    Kenter, M. J. H. & Cohen, A. F. Lancet 368, 1387–1391 (2006).

  16. 16.

    de Visser, S. A Question Based Approach to Drug Development. PhD Thesis, Leiden Univ. (Leiden, the Netherlands, 2003).

  17. 17.

    Cohen, A. F., Burggraaf, J., van Gerven, J. M. A., Moerland, M. & Groeneveld, G. J. Annu. Rev. Pharmacol. Toxicol. 55, 55–74 (2015).

  18. 18.

    Zhang, S. & Babovic, A. Decis. Support Syst. 51, 119–129 (2011).

Download references

Author information

Correspondence to Saco J. de Visser.

Ethics declarations

Competing interests

The authors declare no competing interests.

Supplementary information

Supplementary Materials

Supplementary Figs. 1 and 2 and Supplementary Table 1

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

de Visser, S.J., Cohen, A.F. & Kenter, M.J.H. Integrating scientific considerations into R&D project valuation. Nat Biotechnol 38, 14–18 (2020). https://doi.org/10.1038/s41587-019-0358-x

Download citation